Dextech Medical AB
€0.8500
0
-€0.08-8.41%Friday 14:25
Statistics
Day High
0.906
Day Low
0.906
52W High
1.07
52W Low
0.545
Volume
-
Avg. Volume
-
Mkt Cap
15.71M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-Profit Margin
Unprofitable0Revenue
-589,051.31Net Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Dextech Medical AB engages in the development of drug candidates with application in urological oncology, primarily prostate cancer in Sweden. The company's lead candidate, OsteoDex, which has completed a phase IIb clinical trial for the treatment of bone metastases in castration-resistant prostate cancer, as well as in preclinical stage to treat breast and lung cancer, as well as multiple myeloma. The company is also developing SomaDex, a medication candidate that is based on an endogenous hormone, somatostatin, or the treatment of acromegaly, neuroendocrine tumors, and palliative care in advanced prostate cancer; and PSMA-binding conjugates for the target-specific treatment of mCRPC that overexpresses prostate specific membrane antigen (PSMA). In addition, the company offers GuaDex (formarly CatDex), a technology platform and a charge-modified dextran molecule with tumor-toxic properties used for medication development. Dextech Medical AB was incorporated in 2004 and is based in Uppsala, Sweden.
Show More
CEO
Mr. Anders Ragnarsson Holmberg M.D.
Employees
1
Country
Sweden
ISIN
SE0005881489
WKN
000A14TTX
Listings
0 Comments
Share your thoughts
FAQs
What is Dextech Medical AB stock price today?▼
The current price of LQ0.F is €0.85 EUR — it has decreased by -8.41% in the past 24 hours. Watch Dextech Medical AB stock price performance more closely on the chart.
What is Dextech Medical AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Dextech Medical AB stocks are traded under the ticker LQ0.F.
Is Dextech Medical AB stock price growing?▼
LQ0.F stock has fallen by -3.41% compared to the previous week, the month change is a +0% rise, over the last year Dextech Medical AB has showed a +54.55% increase.
What is Dextech Medical AB market cap?▼
Today Dextech Medical AB has the market capitalization of 15.71M
What is Dextech Medical AB revenue for the last year?▼
Dextech Medical AB revenue for the last year amounts to 0 EUR.
What is Dextech Medical AB net income for the last year?▼
LQ0.F net income for the last year is -589,051.31 EUR.
How many employees does Dextech Medical AB have?▼
As of November 2, 2026, the company has 1 employees.
In which sector is Dextech Medical AB located?▼
Dextech Medical AB operates in the Other sector.
When did Dextech Medical AB complete a stock split?▼
Dextech Medical AB has not had any recent stock splits.
Where is Dextech Medical AB headquartered?▼
Dextech Medical AB is headquartered in Uppsala, Sweden.